In contrast, however, adrenocortical carcinoma (ACC), CHOL, ESCA, KICH, LAML, mesothelioma (MESO), pheochromocytoma and paraganglioma (PCPG), TGCT, THYM, and uveal melanoma (UVM) virtually barely had MET mutations (Figure 2A). This evidence concerns the gene MET and paraganglioma.